Novo Nordisk shares plunge; attention turns to whether this is a generational buying opportunity
NVO Novo Nordisk ADR
$37.53 -0.03%
View chart & analysis → - 1Novo Nordisk shares rose more than 200% in less than 3 years.
- 2Since that peak, Novo Nordisk shares have fallen more than 70% in less than 3 years.
- 3Novo Nordisk achieved a 130% trailing 12-month revenue growth rate over the past 5 years.
So what's the key point?
Novo Nordisk shares have dropped more than 70% from their peak. Since revenue has been growing steadily, it remains to be seen if this decline is an opportunity to buy.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.